Literature DB >> 3624067

Oligomycin E, a new antitumor antibiotic produced by Streptomyces sp. MCI-2225.

K Kobayashi, C Nishino, J Ohya, S Sato, T Mikawa, Y Shiobara, M Kodama, N Nishimoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3624067     DOI： 10.7164/antibiotics.40.1053

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  5 in total

1.  Oligomycins A and C, major secondary metabolites isolated from the newly isolated strain Streptomyces diastaticus.

Authors:  P W Yang; M G Li; J Y Zhao; M Z Zhu; H Shang; J R Li; X L Cui; R Huang; M L Wen
Journal:  Folia Microbiol (Praha)       Date:  2010-03-25       Impact factor: 2.099

2.  Oligomycins as inhibitors of K-Ras plasma membrane localisation.

Authors:  A A Salim; L Tan; X-C Huang; K-J Cho; E Lacey; J F Hancock; R J Capon
Journal:  Org Biomol Chem       Date:  2016-01-14       Impact factor: 3.876

3.  Process optimization for the preparation of oligomycin-loaded folate-conjugated chitosan nanoparticles as a tumor-targeted drug delivery system using a two-level factorial design method.

Authors:  Yuangang Zu; Qi Zhao; Xiuhua Zhao; Shuchong Zu; Li Meng
Journal:  Int J Nanomedicine       Date:  2011-12-20

4.  The biosynthetic pathway to ossamycin, a macrocyclic polyketide bearing a spiroacetal moiety.

Authors:  Oksana Bilyk; Markiyan Samborskyy; Peter F Leadlay
Journal:  PLoS One       Date:  2019-04-30       Impact factor: 3.240

Review 5.  AMPK and Diseases: State of the Art Regulation by AMPK-Targeting Molecules.

Authors:  Olga Tarasiuk; Matteo Miceli; Alessandro Di Domizio; Gabriella Nicolini
Journal:  Biology (Basel)       Date:  2022-07-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.